Advisers to the Food and Drug Administration are weighing the evidence for seven different peptides. Favorable votes would pave the way for easier access.

The committee will discuss whether compounding pharmacies can make the peptides in question. But FDA scientists say there’s little — if any — evidence they work in humans.

A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to back their approval for legal compounding.